Nomura Small Cap Core R6 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Nomura Small Cap Core Fund Class R6 DCZRX
- NAV / 1-Day Return $34.17 / −0.12 %
- Fund Size $4.7B
- Adjusted Expense Ratio 0.690%
- Net Expense Ratio 0.690%
- Fee Level: Distribution Low
- Share Class Type Retirement, Large
- Morningstar Category Small Blend
- Equity Style Box (Funds) Small Blend
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.50%
- Turnover Ratio 26%
Morningstar’s Analysis DCZRX
Will DCZRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 15.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Travere Therapeutics Inc Ordinary Shares | 1.99 | 104M | Healthcare |
Ligand Pharmaceuticals Inc | 1.83 | 96M | Healthcare |
Imax Corp | 1.62 | 85M | Communication Services |
Supernus Pharmaceuticals Inc | 1.62 | 85M | Healthcare |
Federal Signal Corp | 1.50 | 79M | Industrials |
Glaukos Corp | 1.43 | 75M | Healthcare |
Associated Banc-Corp | 1.41 | 74M | Financial Services |
NeoGenomics Inc | 1.40 | 73M | Healthcare |
Kaiser Aluminum Corp | 1.38 | 72M | Basic Materials |
Old National Bancorp | 1.31 | 69M | Financial Services |